Literature DB >> 9672575

Lipid screening in a managed care population.

K C Davis1, M E Cogswell, S L Rothenberg, J P Koplan.   

Abstract

OBJECTIVE: To determine the proportion of patients in a managed care setting who were screened and followed up for high blood cholesterol in accordance with the guidelines from the second report of the National Cholesterol Education Program-Adult Treatment Panel II.
METHODS: The authors conducted a retrospective review of the medical records of 1004 health plan members ages 40-64 who had been continuously enrolled over a period of five years at one of three Prudential Health-Care sites.
RESULTS: Eighty-four percent of patients in the study group had at least one total blood cholesterol level recorded in their medical records; a high density lipoprotein level was recorded for 67%. Cholesterol screening was highest among patients with a diagnosis of hypercholesterolemia (98%), hypertension (96%), or diabetes (94%) and among patients ages 60-64 (94%). Cholesterol screening did not vary by smoking status. More than 86% of those with a diagnosis of hypercholesterolemia were given dietary counseling, medication, or both.
CONCLUSIONS: Compliance with national guidelines in this setting exceeded the Year 2000 goals for lipid management and was comparable with compliance reported in other settings. Routine surveillance of prevention efforts can be a useful way to assess quality of medical care in managed care organizations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672575      PMCID: PMC1308394     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  11 in total

1.  Screening for hypercholesterolemia in a family practice residency.

Authors:  K G Keller; K S Ogle
Journal:  Fam Pract Res J       Date:  1989 Spring-Summer

2.  Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. American College of Physicians. Part 1.

Authors: 
Journal:  Ann Intern Med       Date:  1996-03-01       Impact factor: 25.391

3.  Community screening for hypercholesterolemia.

Authors:  M M Bell; S Joseph
Journal:  J Fam Pract       Date:  1990-10       Impact factor: 0.493

4.  Cholesterol measurement and treatment in community practices.

Authors:  J W Hudson; C W Keefe; A J Hogan
Journal:  J Fam Pract       Date:  1990-08       Impact factor: 0.493

5.  Predictors of screening for hypercholesterolemia in a general internal medicine practice.

Authors:  J M Walsh; R B Baron; W S Browner
Journal:  West J Med       Date:  1993-04

6.  Hypercholesterolemia: case finding in family practice.

Authors:  M K Robinson; M J DeHaven; J B Wallace; T Fost
Journal:  South Med J       Date:  1992-11       Impact factor: 0.954

7.  Primary prevention and coronary heart disease: the economic benefits of lowering serum cholesterol.

Authors:  G Oster; A M Epstein
Journal:  Am J Public Health       Date:  1986-06       Impact factor: 9.308

8.  Should we be measuring blood cholesterol levels in young adults?

Authors:  S B Hulley; T B Newman; D Grady; A M Garber; R B Baron; W S Browner
Journal:  JAMA       Date:  1993-03-17       Impact factor: 56.272

9.  Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities.

Authors:  W H Giles; R F Anda; D H Jones; M K Serdula; R K Merritt; F DeStefano
Journal:  JAMA       Date:  1993-03-03       Impact factor: 56.272

10.  Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel.

Authors:  C T Sempos; J I Cleeman; M D Carroll; C L Johnson; P S Bachorik; D J Gordon; V L Burt; R R Briefel; C D Brown; K Lippel
Journal:  JAMA       Date:  1993-06-16       Impact factor: 56.272

View more
  4 in total

Review 1.  Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model.

Authors:  Catherine Kim; Timothy P Hofer; Eve A Kerr
Journal:  J Gen Intern Med       Date:  2003-10       Impact factor: 5.128

2.  Methylation pattern of ALX4 gene promoter as a potential biomarker for blood-based early detection of colorectal cancer.

Authors:  Rasoul Salehi; Norollah Atapour; Nasimeh Vatandoust; Najmeh Farahani; Fatemeh Ahangari; Ahmad Reza Salehi
Journal:  Adv Biomed Res       Date:  2015-11-30

3.  Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay.

Authors:  Robert Grützmann; Bela Molnar; Christian Pilarsky; Jens K Habermann; Peter M Schlag; Hans D Saeger; Stephan Miehlke; Thomas Stolz; Fabian Model; Uwe J Roblick; Hans-Peter Bruch; Rainer Koch; Volker Liebenberg; Theo Devos; Xiaoling Song; Robert H Day; Andrew Z Sledziewski; Catherine Lofton-Day
Journal:  PLoS One       Date:  2008-11-19       Impact factor: 3.240

4.  Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.

Authors:  Vardit Moshayoff; Ouriel Faktor; Luigi Laghi; Giuseppe Celesti; Tamar Peretz; Dan Keret; Dana Cohen; Eran Israeli
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.